DK160250C - Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte derafInfo
- Publication number
- DK160250C DK160250C DK133080A DK133080A DK160250C DK 160250 C DK160250 C DK 160250C DK 133080 A DK133080 A DK 133080A DK 133080 A DK133080 A DK 133080A DK 160250 C DK160250 C DK 160250C
- Authority
- DK
- Denmark
- Prior art keywords
- alkanon
- analogue
- derivatives
- preparation
- acceptable salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2887279 | 1979-04-10 | ||
| US06/028,872 US4254130A (en) | 1979-04-10 | 1979-04-10 | Piperidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK133080A DK133080A (da) | 1980-10-11 |
| DK160250B DK160250B (da) | 1991-02-18 |
| DK160250C true DK160250C (da) | 1991-07-22 |
Family
ID=21845986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK133080A DK160250C (da) | 1979-04-10 | 1980-03-27 | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte deraf |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4254130A (da) |
| JP (1) | JPS55139360A (da) |
| AT (1) | AT376207B (da) |
| AU (1) | AU536463B2 (da) |
| BE (1) | BE882704A (da) |
| CA (1) | CA1123439A (da) |
| CH (1) | CH648019A5 (da) |
| DE (1) | DE3005948A1 (da) |
| DK (1) | DK160250C (da) |
| ES (1) | ES8103734A1 (da) |
| FR (1) | FR2453853A1 (da) |
| IL (1) | IL59157A (da) |
| IT (1) | IT1144079B (da) |
| NL (1) | NL190664C (da) |
| NO (1) | NO154964C (da) |
| NZ (1) | NZ192615A (da) |
| SE (1) | SE448727B (da) |
| ZA (1) | ZA80331B (da) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231105A (en) * | 1987-06-02 | 1993-07-27 | Ajinomoto Co., Inc. | Ethylamine derivatives and antihypertensives containing the same |
| DE3917241A1 (de) * | 1989-05-26 | 1990-11-29 | Schaper & Bruemmer Gmbh | 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate |
| US5190029A (en) * | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| US5182097A (en) * | 1991-02-14 | 1993-01-26 | Virginia Commonwealth University | Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| JP2548800Y2 (ja) * | 1991-09-13 | 1997-09-24 | 株式会社小糸製作所 | 自動車用ヘッドランプ |
| HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
| US5631375A (en) * | 1992-04-10 | 1997-05-20 | Merrell Pharmaceuticals, Inc. | Process for piperidine derivatives |
| AU671822B2 (en) * | 1992-04-10 | 1996-09-12 | Aventisub Ii Inc. | 4-diphenylmethyl piperidine derivatives and process for their preparation |
| US5654433A (en) * | 1993-01-26 | 1997-08-05 | Merrell Pharmaceuticals Inc. | Process for piperidine derivatives |
| DE69433346T2 (de) | 1993-06-24 | 2004-09-09 | Albany Molecular Research, Inc. | Herstellung von Verbindungen, die in der Produktion von Piperidin-Derivaten nützlich sind |
| US20020007068A1 (en) * | 1999-07-16 | 2002-01-17 | D'ambra Thomas E. | Piperidine derivatives and process for their production |
| US6147216A (en) * | 1993-06-25 | 2000-11-14 | Merrell Pharmaceuticals Inc. | Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| AU699559B2 (en) | 1993-06-25 | 1998-12-10 | Aventisub Ii Inc. | Novel intermediates for the preparation of antihistaminic piperidine derivatives |
| CN1148849A (zh) | 1994-05-18 | 1997-04-30 | 赫彻斯特马里恩鲁斯公司 | 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法 |
| US20030045722A1 (en) * | 1994-05-18 | 2003-03-06 | Henton Daniel R. | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| MX9701305A (es) | 1994-08-25 | 1998-05-31 | Merrell Pharma Inc | Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas. |
| EP0812195B1 (en) * | 1995-02-28 | 2002-10-30 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol compounds |
| NZ306319A (en) * | 1995-05-08 | 1999-08-30 | Hoechst Marion Roussel Inc | 1-alkylphenyl substituted 4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butanol derivatives and medicaments |
| US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| US6211199B1 (en) | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US6201124B1 (en) * | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US5922737A (en) * | 1996-02-21 | 1999-07-13 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases |
| US5998439A (en) * | 1996-02-21 | 1999-12-07 | Hoescht Marion Roussel, Inc. | Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| US5932571A (en) * | 1996-02-21 | 1999-08-03 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases |
| KR100514264B1 (ko) * | 1997-08-26 | 2005-09-15 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올-충혈완화제 조합용 제약 조성물 |
| US6673933B2 (en) | 1998-07-02 | 2004-01-06 | Aventis Pharmaceutical Inc. | Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| US6683094B2 (en) | 1998-07-02 | 2004-01-27 | Aventis Pharmaceuticals Inc. | Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| US6613907B2 (en) | 2000-11-08 | 2003-09-02 | Amr Technology, Inc. | Process for the production of piperidine derivatives with microorganisms |
| TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| EP1616861A3 (en) * | 2004-06-15 | 2006-02-08 | Dipharma S.p.A. | A process for the preparation of keto compounds |
| US7498345B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US7498443B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of carebastine |
| NZ568694A (en) | 2005-11-09 | 2011-09-30 | Zalicus Inc | Method, compositions, and kits for the treatment of medical conditions |
| ITMI20061492A1 (it) * | 2006-07-27 | 2008-01-28 | Archimica Srl | Processo per la preparazione di fexofenadina. |
| US20080161324A1 (en) * | 2006-09-14 | 2008-07-03 | Johansen Lisa M | Compositions and methods for treatment of viral diseases |
| ITMI20070987A1 (it) * | 2007-05-16 | 2008-11-17 | Dipharma Francis Srl | Procedimento per la preparazione di composti chetonici |
| WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| EP2289867A3 (en) | 2009-08-19 | 2012-04-25 | Jubilant Organosys Limited | A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof |
| US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
| EP2371817A1 (en) | 2010-04-01 | 2011-10-05 | Arevipharma GmbH | Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof |
| EP2578570A1 (en) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
| EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
| CN102659667B (zh) * | 2012-04-20 | 2013-08-14 | 浙江启明药业有限公司 | 一种非索非那定关键中间体的合成方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1242169A (en) * | 1969-04-09 | 1971-08-11 | Ucb Sa | Piperidine derivatives |
| US3965257A (en) * | 1972-01-28 | 1976-06-22 | Richardson-Merrell Inc. | Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions |
| BE794596A (fr) * | 1972-01-28 | 1973-05-16 | Richardson Merrell Inc | Piperidinoalcanone-oximes substituees et leur procede de preparation |
| US3806526A (en) * | 1972-01-28 | 1974-04-23 | Richardson Merrell Inc | 1-aroylalkyl-4-diphenylmethyl piperidines |
| BE794598A (fr) * | 1972-01-28 | 1973-05-16 | Richardson Merrell Inc | Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation |
| ZA728544B (en) * | 1972-01-28 | 1974-02-27 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
| US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
| US3941795A (en) * | 1974-02-08 | 1976-03-02 | Richardson-Merrell Inc. | α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES |
| US3931197A (en) * | 1974-02-08 | 1976-01-06 | Richardson-Merrell Inc. | Substituted piperidine derivatives |
| US3946022A (en) * | 1974-03-04 | 1976-03-23 | Richardson-Merrell Inc. | Piperidine derivatives |
| US3922276A (en) * | 1974-12-11 | 1975-11-25 | Robins Co Inc A H | 1-Substituted-4-benzylidenepiperidines |
| US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
-
1979
- 1979-04-10 US US06/028,872 patent/US4254130A/en not_active Expired - Lifetime
-
1980
- 1980-01-15 NZ NZ192615A patent/NZ192615A/xx unknown
- 1980-01-18 CA CA344,022A patent/CA1123439A/en not_active Expired
- 1980-01-18 IL IL59157A patent/IL59157A/xx unknown
- 1980-01-21 ZA ZA00800331A patent/ZA80331B/xx unknown
- 1980-01-29 AU AU55018/80A patent/AU536463B2/en not_active Expired
- 1980-02-07 NL NL8000762A patent/NL190664C/xx not_active IP Right Cessation
- 1980-02-15 IT IT47919/80A patent/IT1144079B/it active
- 1980-02-16 DE DE19803005948 patent/DE3005948A1/de active Granted
- 1980-02-26 CH CH1528/80A patent/CH648019A5/de not_active IP Right Cessation
- 1980-03-06 AT AT0126080A patent/AT376207B/de not_active IP Right Cessation
- 1980-03-26 ES ES489933A patent/ES8103734A1/es not_active Expired
- 1980-03-27 DK DK133080A patent/DK160250C/da not_active IP Right Cessation
- 1980-04-02 JP JP4207180A patent/JPS55139360A/ja active Pending
- 1980-04-08 SE SE8002635A patent/SE448727B/sv not_active IP Right Cessation
- 1980-04-09 FR FR8007993A patent/FR2453853A1/fr active Granted
- 1980-04-09 BE BE0/200162A patent/BE882704A/fr not_active IP Right Cessation
- 1980-04-09 NO NO801015A patent/NO154964C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK160250B (da) | 1991-02-18 |
| FR2453853B1 (da) | 1982-07-09 |
| NO154964C (no) | 1987-01-21 |
| ES489933A0 (es) | 1981-03-16 |
| AU536463B2 (en) | 1984-05-10 |
| US4254130A (en) | 1981-03-03 |
| IT8047919A0 (it) | 1980-02-15 |
| NL190664C (nl) | 1994-06-16 |
| FR2453853A1 (fr) | 1980-11-07 |
| AT376207B (de) | 1984-10-25 |
| CA1123439A (en) | 1982-05-11 |
| NO154964B (no) | 1986-10-13 |
| DE3005948A1 (de) | 1980-10-30 |
| NZ192615A (en) | 1982-02-23 |
| ES8103734A1 (es) | 1981-03-16 |
| NL190664B (nl) | 1994-01-17 |
| DK133080A (da) | 1980-10-11 |
| IL59157A (en) | 1984-02-29 |
| SE8002635L (sv) | 1980-10-11 |
| IL59157A0 (en) | 1980-05-30 |
| IT1144079B (it) | 1986-10-29 |
| NO801015L (no) | 1980-10-13 |
| DE3005948C2 (da) | 1989-10-05 |
| BE882704A (fr) | 1980-07-31 |
| AU5501880A (en) | 1980-10-16 |
| CH648019A5 (de) | 1985-02-28 |
| JPS55139360A (en) | 1980-10-31 |
| ZA80331B (en) | 1981-01-28 |
| SE448727B (sv) | 1987-03-16 |
| NL8000762A (nl) | 1980-10-14 |
| ATA126080A (de) | 1984-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK160250C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte deraf | |
| DK161770C (da) | Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf | |
| DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
| DK160940C (da) | Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf | |
| DK156434C (da) | Analogifremgangsmaade til fremstilling af sulfonylurinstoffer eller deres fysiologisk acceptable salte | |
| DK163244C (da) | Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf | |
| DK151623C (da) | Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK151330C (da) | Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK150483C (da) | Analogifremgangsmaade til fremstilling af trans-3-(4-oxo-4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf med farmaceutisk acceptablesyrer | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK149269C (da) | Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf | |
| DK147940C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede thiazol-2-oxamsyrederivater eller salte eller estre deraf | |
| DK151805C (da) | Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf | |
| DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
| DK149077C (da) | Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK143105C (da) | Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf | |
| DK152208C (da) | Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf | |
| DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf | |
| DK148019C (da) | Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |